10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 6,316,000 | $42,380,360 | +1% | 0.63% |
| 2. | Millennium Management Israel Englander | 1,710,140 | $11,475,039 | +13% | 0% |
| 3. | First Eagle Investment Management Jean-Marie Eveillard | 1,238,895 | $8,312,985 | +37% | 0.02% |
| 4. | Parkman Healthcare Partners Greg Martinez | 847,675 | $5,687,899 | +1% | 0.59% |
| 5. | D E Shaw D. E. Shaw | 761,333 | $5,108,544 | -8% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.73 | 60,000 | $524,064.00 | 6,796,190 | 2025-03-04 | Filing | |
| $5.31 | 50,000 | $265,630.00 | 6,523,095 | 2024-09-16 | Filing | |
| $5.96 | 84,000 | $501,034.80 | 1,223,441 | 2024-08-15 | Filing | |
| $6.00 | 85,000 | $510,314.50 | 6,473,095 | 2024-08-14 | Filing | |
| $5.88 | 45,000 | $264,600.00 | 6,388,095 | 2024-06-11 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.97 | 50,000 | $398,460.00 | 364,081 | 2025-03-17 | Filing | |
| $24.02 | 1,700 | $40,828.39 | 1,036,441 | 2022-11-15 | Filing | |
| $21.97 | 200 | $4,394.00 | 1,038,141 | 2022-11-15 | Filing | |
| $21.18 | 1,600 | $33,890.08 | 1,038,341 | 2022-11-15 | Filing | |
| $20.12 | 46,500 | $935,580.00 | 1,039,941 | 2022-11-15 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 242,411 | $707,840 | 0% | |
| 2. | 307 | $752 | 0% | |
| 3. | 18,751 | $46 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |